Guo Jing, Bi Xue, Chen Shan-Na, Chen Song, He Guang-Hui, Wu Bin, Zhang Wei, Wang Jian
Clinical College of Ophthalmology, Tianjin Medical University, Tianjin 300070, China.
Department of Ophthalmology, Guangdong Hospital of Traditional Chinese Medicine, Guangzhou 510120, Guangdong Province, China.
Int J Ophthalmol. 2020 Nov 18;13(11):1758-1764. doi: 10.18240/ijo.2020.11.12. eCollection 2020.
To explore the efficacy of minimally invasive vitrectomy (MIV) with or without internal limiting membrane (ILM) peeling on the treatment of diabetic macular edema (DME) in proliferative diabetic retinopathy (PDR) combining with preoperative anti-vascular endothelial growth factor (anti-VEGF) injection.
Totally 132 eyes (132 patients) diagnosed PDR with DME were included between June 2015 and June 2018 in Tianjin Eye Hospital. The single MIV treatment group included 68 eyes and the MIV combined with ILM peeling group included 64 eyes. Anti-VEGF drugs were injected intravitreally 1wk before the operation and the period of follow-up was 1 to 3y. Best-corrected visual acuity (BCVA), central retinal thickness (CRT), total macular volume (TMV), macular edema (ME) severity, intraocular pressure (IOP), and complications were recorded. Prognostic factors of visual acuity following ILM peeling were analyzed.
The BCVA was higher than preoperative values at 1, 3, 6, and 12mo after surgery in both groups (all <0.05). At 6 and 12mo, the BCVA of the combined group was significantly higher than that of the MIV only group (0.52±0.23 0.64±0.29 logMAR, =0.011 in 6mo; 0.41±0.25 0.52±0.25 logMAR, =0.008 in 12mo). Mean CRT values postoperative were significantly lower than preoperative values in both groups from the 1 month (1mo 397.65±106.18 451.94±118.88 µm in MIV only group; 388.88±108.68 464.36±111.53 µm in combined group; both <0.05) and decreased gradually. The differences between the two groups were statistically significant at 3, 6, and 12mo (=0.004, 0.003, 0.00 respectively). The TMV was decreased from the 3 month in the single treatment group (3mo 11.14±1.66 12.20±2.09 mm, <0.05). At 12mo, the proportion of eyes with edema that had CRT more than 350 µm was significantly lower than before surgery (13.24% 77.94% in MIV only group; 1.56% 81.25% in combined group; both <0.05). There was no significant difference in the recurrence incidence of macular epiretinal membrane, ME, transient IOP increase, vitreous rebleeding, or traction retinal detachment between the two groups. BCVA after ILM excision was positively correlated with the CRT and ME degree before and after surgery (=0.430, 0.485, respectively; <0.05).
MIV combined with ILM peeling accelerates the absorption of ME, improves vision, reduces the postoperative CRT and TMV, and reduces the recurrence rate of postoperative ME.
探讨微创玻璃体切除术(MIV)联合或不联合内界膜(ILM)剥除术治疗增殖性糖尿病视网膜病变(PDR)合并糖尿病性黄斑水肿(DME)时术前抗血管内皮生长因子(抗VEGF)注射的疗效。
2015年6月至2018年6月期间,天津眼科医院共纳入132例(132只眼)诊断为PDR合并DME的患者。单纯MIV治疗组68只眼,MIV联合ILM剥除组64只眼。术前1周玻璃体腔内注射抗VEGF药物,随访1至3年。记录最佳矫正视力(BCVA)、视网膜中央厚度(CRT)、黄斑总体积(TMV)、黄斑水肿(ME)严重程度、眼压(IOP)及并发症。分析ILM剥除术后视力的预后因素。
两组术后1、3、6和12个月时的BCVA均高于术前值(均P<0.05)。在6个月和12个月时,联合组的BCVA显著高于单纯MIV组(6个月时:0.52±0.23比0.64±0.29logMAR,P=0.011;12个月时:0.41±0.25比0.52±0.25logMAR,P=0.008)。两组术后平均CRT值自术后1个月起均显著低于术前值(单纯MIV组:1个月时397.65±106.18比451.94±118.88μm;联合组:388.88±108.68比464.36±111.53μm,均P<0.05),且逐渐降低。两组在术后3、6和12个月时的差异有统计学意义(分别为P=0.004、0.003、0.00)。单纯治疗组自术后3个月起TMV降低(3个月时:11.14±1.66比12.20±2.09mm³,P<0.05)。在12个月时,CRT大于350μm的水肿眼比例显著低于术前(单纯MIV组:13.24%比77.94%;联合组:1.56%比81.25%,均P<0.05)。两组在黄斑视网膜前膜、ME、短暂性IOP升高、玻璃体再出血或牵拉性视网膜脱离的复发率方面无显著差异。ILM切除术后的BCVA与手术前后的CRT及ME程度呈正相关(分别为r=0.430、0.485,均P<0.05)。
MIV联合ILM剥除术可加速ME吸收,提高视力,降低术后CRT和TMV,并降低术后ME复发率。